Imaging Agents
VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent
Published in Cancer Weekly, July 21st, 2009
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the commercial launch of its new Cat-K FAST(TM) imaging agent for measuring and monitoring Cathepsin K activity associated with disease progression and therapeutic response in vivo. Cathepsin K expression is well known as a key biomarker and therapeutic target in a range of bone-related diseases, including cancer metastasis to bone, as well as in atherosclerosis. The new Cat-K FAST(TM) agent is expected to significantly expand research and enhance drug development in these areas by enabling real time imaging of Cat-K activity.
Cat-K FAST(TM) represents an additional...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-07-21)
More Articles from Cancer Weekly
- Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals' AEOL 10150 Significantly Increases Survival in Mice Exposed to Radiation when Administered After Exposure - ARYx Therapeutics, Inc.
ARYx Therapeutics Announces Results of Phase 2/3 Clinical Trial on Anticoagulant Agent Tecarfarin - Breast Cancer
Are Breast Cancer Patients Being Kept In the Dark? - Cancer Gene Therapy
New cancer gene therapy research from M. Idogawa and colleagues discussed - Cancer Gene Therapy
Research from J. Ma and co-authors in the area of cancer gene therapy published - Cancer Gene Therapy
Researchers at University of Washington target cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
